NovaBridge Biosciences
Status: Publicly traded
Direct answer
NovaBridge Biosciences is publicly traded on NASDAQ under the ticker NBP.
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is...
Can you invest in NovaBridge Biosciences?
Yes. NovaBridge Biosciences trades publicly on NASDAQ as NBP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NovaBridge Biosciences
Detailed equity research is provided by MarketSnap.